These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19207188)

  • 1. High prevalence of ovarian cysts in premenopausal women receiving sirolimus and tacrolimus after clinical islet transplantation.
    Alfadhli E; Koh A; Albaker W; Bhargava R; Ackerman T; McDonald C; Ryan EA; Shapiro AM; Senior PA
    Transpl Int; 2009 Jun; 22(6):622-5. PubMed ID: 19207188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen.
    Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
    Transpl Int; 2005 Nov; 18(11):1226-30. PubMed ID: 16221151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Incidence of Ovarian Cysts in Women Receiving mTOR Inhibitors After Renal Transplantation.
    Bachmann F; Glander P; Budde K; Bachmann C
    J Womens Health (Larchmt); 2018 Mar; 27(3):394-398. PubMed ID: 29087803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the female reproductive system in islet recipient receiving immunosuppression.
    Del Olmo Garcia MI; Lauriola V; Aracena AG; Messinger S; Corrales A; Ricordi C; Alejandro R
    Cell Transplant; 2011; 20(10):1649-51. PubMed ID: 21396172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal decline in sirolimus elimination immediately after pancreatic islet transplantation.
    Sato E; Shimomura M; Masuda S; Yano I; Katsura T; Matsumoto S; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Inui K
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):492-500. PubMed ID: 17220565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
    Maffi P; Bertuzzi F; De Taddeo F; Magistretti P; Nano R; Fiorina P; Caumo A; Pozzi P; Socci C; Venturini M; del Maschio A; Secchi A
    Diabetes Care; 2007 May; 30(5):1150-5. PubMed ID: 17259471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three cases of alopecia following clinical islet transplantation.
    Zuk DM; Koh A; Imes S; Shapiro AM; Senior PA
    Am J Transplant; 2011 Jan; 11(1):163-8. PubMed ID: 21199356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient.
    Kaplan B; West P; Neeley H; Martellotto J; Iqbal R; Gangemi A; Hatipoglu B; Benedetti E; Oberholzer J
    Clin Transplant; 2008; 22(2):250-3. PubMed ID: 18339148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian manifestations in women with autosomal dominant polycystic kidney disease.
    Heinonen PK; Vuento M; Maunola M; Ala-Houhala I
    Am J Kidney Dis; 2002 Sep; 40(3):504-7. PubMed ID: 12200801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer.
    Shushan A; Peretz T; Uziely B; Lewin A; Mor-Yosef S
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):141-4. PubMed ID: 8571997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.
    Gillard P; Ling Z; Mathieu C; Crenier L; Lannoo M; Maes B; Roep B; Gorus F; Pipeleers D; Keymeulen B
    Transplantation; 2008 Jan; 85(2):256-63. PubMed ID: 18212631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.
    Toso C; Morel P; Bucher P; Mathe Z; Demuylder-Mischler S; Bosco D; Berney T; Oberholzer J; Shapiro J; Oberholzer J; Philippe J
    Transplantation; 2003 Oct; 76(7):1133-4. PubMed ID: 14557767
    [No Abstract]   [Full Text] [Related]  

  • 13. Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients.
    Hakeam HA; Al-Jedai AH; Raza SM; Hamawi K
    Ann Transplant; 2008; 13(2):46-53. PubMed ID: 18566560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.
    Barshes NR; Lee T; Goodpasture S; Brunicardi FC; Alejandro R; Ricordi C; Soltes G; Barth M; Hamilton D; Goss JA
    Transplant Proc; 2004 May; 36(4):1127-9. PubMed ID: 15194393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-induced interstitial pneumonitis in an islet transplant recipient.
    Digon BJ; Rother KI; Hirshberg B; Harlan DM
    Diabetes Care; 2003 Nov; 26(11):3191. PubMed ID: 14578266
    [No Abstract]   [Full Text] [Related]  

  • 16. Resolution of severe atopic dermatitis after tacrolimus withdrawal.
    Ponte GM; Baidal DA; Romanelli P; Faradji RN; Poggioli R; Cure P; Froud T; Selvaggi G; Pileggi A; Ricordi C; Alejandro R
    Cell Transplant; 2007; 16(1):23-30. PubMed ID: 17436852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian Cancer: Prevalence in Incidental Simple Adnexal Cysts Initially Identified in CT Examinations of the Abdomen and Pelvis.
    Boos J; Brook OR; Fang J; Brook A; Levine D
    Radiology; 2018 Jan; 286(1):196-204. PubMed ID: 28914598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation.
    Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
    Transplant Proc; 2005 Mar; 37(2):1326-7. PubMed ID: 15848711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.